Nuwellis (NUWE) FCF Margin (2013 - 2026)
Nuwellis' (NUWE) quarterly FCF Margin came in at 170.54% in Q2 2026, down 5512.0% on a YoY basis from 3.15% in Q2 2025, and down 30.43% quarter-over-quarter from 130.75% in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) FCF Margin (2013 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported FCF Margin for 14 consecutive years, with 170.54% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 5512.0% year-over-year to 170.54%; the trailing twelve-month figure through Jun 2026 stood at 142.83% (down 4053.0% YoY), and the FY2025 full-year result was 131.8%, down 2138.0% from the prior year.
- FCF Margin declined to 170.54% in Q2 2026 per NUWE's latest filing, from 130.75% in the prior quarter.
- Across five years, FCF Margin topped out at 65.76% in Q4 2024 and bottomed at 335.1% in Q1 2023.
- Historically, FCF Margin has averaged 159.13% across 5 years, with a median of 142.92% in 2022.
- The sharpest annual moves came in 2023 and 2024: FCF Margin tumbled 8085 bps in 2023, then surged 17942 bps in 2024.
- Over 5 years, FCF Margin stood at 134.5% in 2022, then grew by 21 bps to 106.55% in 2023, then jumped by 38 bps to 65.76% in 2024, then sank by 89 bps to 124.5% in 2025, then sank by 37 bps to 170.54% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 170.54%, 130.75%, and 124.5% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.73% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -170.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -170.54% |
| Mar 31, 2026 | -130.75% |
| Dec 31, 2025 | -124.50% |
| Sep 30, 2025 | -151.33% |
| Jun 30, 2025 | -115.42% |
| Mar 31, 2025 | -133.19% |
| Dec 31, 2024 | -65.76% |
| Sep 30, 2024 | -103.72% |
| Jun 30, 2024 | -126.62% |
| Mar 31, 2024 | -155.68% |
| Dec 31, 2023 | -106.55% |
| Sep 30, 2023 | -163.60% |
| Jun 30, 2023 | -255.57% |
| Mar 31, 2023 | -335.10% |
| Dec 31, 2022 | -134.50% |
| Sep 30, 2022 | -158.79% |
| Jun 30, 2022 | -178.45% |
| Mar 31, 2022 | -254.26% |
| Dec 31, 2021 | -254.75% |
| Sep 30, 2021 | -245.01% |